Objective: To observe the efficacy of using benazepril to heal hypertension complicated with 2-type diabetic nephropathy.
目的：观察苯那普利治疗高血压合并2型糖尿病肾病的疗效。
AIM: To observe the changes of serum Creactive protein expression level in different periods of type 2 diabetic nephropathy.
目的：观察血清c反应蛋白在2型糖尿病肾病不同时期的变化。
Objective To investigate the predictive value of urinary low molecular weight proteins for progression of diabetic nephropathy in type 2 diabetic patient with microalbuminuria.
目的观察低分子蛋白尿对2型糖尿病微量蛋白尿患者进展到临床糖尿病肾病的预后判断作用。
Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.
目的研究血管紧张素转换酶抑制剂(acei)和血管紧张素受体拮抗剂(arb)对2型糖尿病肾病患者肾功能的保护作用。
Objective: to establish two kinds of models of type 2 diabetic nephropathy in rats and to compare them.
目的：建立两种2型糖尿病肾病大鼠模型，比较两种模型的优缺点。
Objective To explore the relationship between vascular endothelial growth factor and type 2 diabetic nephropathy .
目的探讨血管内皮生长因子与2型糖尿病肾病的关系。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病（DN）患者尿白蛋白排泄率（UAER）的影响。
Objective: to investigate the serum level of leptin in patients with type 2 diabetic nephropathy and its relation factors.
目的：探讨2型糖尿病肾病患者血清瘦素水平及其影响因素。
Methods: 112 cases of type 2 diabetic nephropathy were divided into two groups, involved in a randomized control clinical trial.
方法：112例2型糖尿病性肾病患者随机分为①对照组：仅用包括降糖疗法的一般糖尿病性肾病治疗方法；
Conclusion: low molecular weight heparin calcic is safer and more effective than the control group in the treatment of type 2 diabetic nephropathy.
结论：低分子肝素钙治疗2型糖尿病肾病是安全有效的。
Method: Case control study was used to observe the changes of serum lipid levels in type 2 diabetes patients and type 2 diabetic nephropathy patients with hypertension or normotension.
方法：采用病例对照研究的方法观察2型糖尿病、2型糖尿病肾病合并高血压和不合并高血压患者血脂水平的变化。
Objective: to study the influence of valsartan to correlated inflammatory cytokine in early stage of type 2 diabetic nephropathy and the protection to diabetic nephropathy.
目的：观察缬沙坦对2型糖尿病早期肾病相关炎症因子的影响及对糖尿病肾病的保护作用。
Conclusion:Allele T of AGT gene M235T, the longer diabetes duration and history of hypertension were associated with higher risk of nephropathy in type 2 diabetic patients.
结论：AGT基因235T等位基因、糖尿病病程长、既往高血压史均可增加2型糖尿病患者合并肾病的危险；
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.
预测因子与2型糖尿病肾病和高血压患者心血管事件的预测因子：蛋白尿因素。
Results: Some pathological characteristics of diabetic nephropathy exist in type 2 diabetic rats.
结果：大鼠肾脏病理符合2型糖尿病肾病的改变。
Conclusion BMD of elder male type 2 diabetic patients were affected by varied factors, especially by gradually deteriorating diabetic nephropathy.
结论老年男性2型糖尿病患者的骨密度与多种因素有关，糖尿病肾病的进展是其重要的影响因素。
Conclusion the more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
结论：多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。
Conclusion the more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
结论：多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。
应用推荐